{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:12:08Z","timestamp":1791295928857,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CAEN-ISN"},{"DOI":"10.13039\/501100001675","name":"International Brain Research Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001675","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Newton Advanced Fellowship"},{"name":">CAPES studentship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s11064-015-1681-3","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T01:21:58Z","timestamp":1438219318000},"page":"568-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Battling Alzheimer\u2019s Disease: Targeting SUMOylation-Mediated Pathways"],"prefix":"10.1007","volume":"41","author":[{"given":"Wagner Carbolin","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla In\u00eas","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Cimarosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"key":"1681_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer\u2019s Dement 9:63\u201375","journal-title":"Alzheimer\u2019s Dement"},{"key":"1681_CR2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nrd2075","volume":"5","author":"D Dam Van","year":"2006","unstructured":"Van Dam D, De Deyn PP (2006) Drug discovery in dementia: the role of rodent models. Nat Rev Drug Discov 5:956\u2013970","journal-title":"Nat Rev Drug Discov"},{"key":"1681_CR3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u2013185","journal-title":"Science"},{"key":"1681_CR4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","volume":"18","author":"K Herrup","year":"2015","unstructured":"Herrup K (2015) The case for rejecting the amyloid cascade hypothesis. Nat Neurosci 18:794\u2013799","journal-title":"Nat Neurosci"},{"key":"1681_CR5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer\u2019s disease. N Engl J Med 362:329\u2013344","journal-title":"N Engl J Med"},{"key":"1681_CR6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","volume":"82","author":"TL Spires-Jones","year":"2014","unstructured":"Spires-Jones TL, Hyman BT (2014) The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease. Neuron 82:756\u2013771","journal-title":"Neuron"},{"key":"1681_CR7","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913\u20134917","journal-title":"Proc Natl Acad Sci USA"},{"key":"1681_CR8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat Rev Mol Cell Biol 8:101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1681_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/bcp.12621","volume":"80","author":"S West","year":"2015","unstructured":"West S, Bhugra P (2015) Emerging drug targets for A\u03b2 and tau in Alzheimer\u2019s disease: a systematic review. Br J Clin Pharmacol 80:221\u2013234","journal-title":"Br J Clin Pharmacol"},{"key":"1681_CR10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainres.2006.03.107","volume":"1094","author":"E Thornton","year":"2006","unstructured":"Thornton E, Vink R, Blumbergs PC, Heuvel CVD (2006) Soluble amyloid precursor protein \u03b1 reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res 1094:38\u201346","journal-title":"Brain Res"},{"key":"1681_CR11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1471-4159.1996.67010277.x","volume":"67","author":"ME Harris","year":"1996","unstructured":"Harris ME, Wang Y, Pedigo NW Jr, Hensley K, Butterfield DA, Carney JM (1996) Amyloid \u03b2 peptide (25\u201335) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 67:277\u2013286","journal-title":"J Neurochem"},{"key":"1681_CR12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","volume":"32","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA, Lauderback CM (2002) Lipid peroxidation and protein oxidation in Alzheimer\u2019s disease brain: potential causes and consequences involving amyloid-\u03b2-peptide associated free radical oxidative stress. Free Radic Biol Med 32:1050\u20131060","journal-title":"Free Radic Biol Med"},{"key":"1681_CR13","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","volume":"285","author":"A Demuro","year":"2010","unstructured":"Demuro A, Parker I, Stutzmann GE (2010) Calcium signaling and amyloid toxicity in Alzheimer disease. J Biol Chem 285:12463\u201312468","journal-title":"J Biol Chem"},{"key":"1681_CR14","doi-asserted-by":"crossref","first-page":"a006262","DOI":"10.1101\/cshperspect.a006262","volume":"2","author":"CL Masters","year":"2012","unstructured":"Masters CL, Selkoe DJ (2012) Biochemistry of amyloid \u03b2-protein and amyloid deposits in Alzheimer\u2019s disease. Cold Spring Harb Perspect Med 2:a006262","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1681_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","volume":"44","author":"DM Walsh","year":"2004","unstructured":"Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease. Neuron 44:181\u2013193","journal-title":"Neuron"},{"key":"1681_CR16","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.1074\/jbc.R800050200","volume":"284","author":"ET Yeh","year":"2009","unstructured":"Yeh ET (2009) SUMOylation and De-SUMOylation: wrestling with life\u2019s processes. J Biol Chem 284:8223\u20138227","journal-title":"J Biol Chem"},{"key":"1681_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrm3099","volume":"12","author":"C Grabbe","year":"2011","unstructured":"Grabbe C, Husnjak K, Dikic I (2011) The spatial and temporal organization of ubiquitin networks. Nat Rev Mol Cell Biol 12:295\u2013307","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1681_CR18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5483\/BMBRep.2014.47.9.128","volume":"47","author":"CW Park","year":"2014","unstructured":"Park CW, Ryu KY (2014) Cellular ubiquitin pool dynamics and homeostasis. BMB Rep 47:475\u2013482","journal-title":"BMB Rep"},{"key":"1681_CR19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/jnc.12347","volume":"127","author":"V Silveirinha","year":"2013","unstructured":"Silveirinha V, Stephens GJ, Cimarosti H (2013) Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia. J Neurochem 127:580\u2013591","journal-title":"J Neurochem"},{"key":"1681_CR20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbamcr.2007.03.017","volume":"1773","author":"V Dorval","year":"2007","unstructured":"Dorval V, Fraser PE (2007) SUMO on the road to neurodegeneration. Biochem Biophys Acta 1773:694\u2013706","journal-title":"Biochem Biophys Acta"},{"key":"1681_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1358\/dnp.2009.22.5.1378636","volume":"22","author":"DB Anderson","year":"2009","unstructured":"Anderson DB, Wilkinson KA, Henley JM (2009) Protein SUMOylation in neuropathological conditions. Drug News Perspect 22:255\u2013265","journal-title":"Drug News Perspect"},{"key":"1681_CR22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.brainresrev.2010.04.002","volume":"64","author":"KA Wilkinson","year":"2010","unstructured":"Wilkinson KA, Nakamura Y, Henley JM (2010) Targets and consequences of protein SUMOylation in neurons. Brain Res Rev 64:195\u2013212","journal-title":"Brain Res Rev"},{"key":"1681_CR23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-12-386041-5.00004-2","volume":"288","author":"KD Sarge","year":"2011","unstructured":"Sarge KD, Park-Sarge OK (2011) SUMO and its role in human diseases. Int Rev Cell Mol Biol 288:167\u2013183","journal-title":"Int Rev Cell Mol Biol"},{"key":"1681_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnmol.2014.00063","volume":"7","author":"G Atkin","year":"2014","unstructured":"Atkin G, Paulson H (2014) Ubiquitin pathways in neurodegenerative disease. Front Mol Neurosci 7:63","journal-title":"Front Mol Neurosci"},{"key":"1681_CR25","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1074\/jbc.M510127200","volume":"281","author":"V Dorval","year":"2006","unstructured":"Dorval V, Fraser PE (2006) Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and \u03b1-synuclein. J Biol Chem 281:9919\u20139924","journal-title":"J Biol Chem"},{"key":"1681_CR26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","volume":"58","author":"L Martin","year":"2011","unstructured":"Martin L, Latypova X, Terro F (2011) Post-translational modifications of tau protein: Implications for Alzheimer\u2019s disease. Neurochem Int 58:458\u2013471","journal-title":"Neurochem Int"},{"key":"1681_CR27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1258\/ebm.2010.010327","volume":"236","author":"BM Riederer","year":"2011","unstructured":"Riederer BM, Leuba G, Vernay A, Riederer IM (2011) The role of the ubiquitin proteasome system in Alzheimer\u2019s disease. Exp Biol Med 236:268\u2013276","journal-title":"Exp Biol Med"},{"key":"1681_CR28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnmol.2014.00042","volume":"7","author":"S Tenreiro","year":"2014","unstructured":"Tenreiro S, Eckermann K, Outeiro TF (2014) Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci 7:42","journal-title":"Front Mol Neurosci"},{"key":"1681_CR29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1073\/pnas.0235361100","volume":"100","author":"Y Li","year":"2003","unstructured":"Li Y, Wang H, Wang S, Quon D, Liu YW, Cordell B (2003) Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc Natl Acad Sci USA 100:259\u2013264","journal-title":"Proc Natl Acad Sci USA"},{"key":"1681_CR30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.yexcr.2006.10.028","volume":"313","author":"AT Weeraratna","year":"2007","unstructured":"Weeraratna AT, Kalehua A, Deleon I, Bertak D, Maher G, Wade MS et al (2007) Alterations in immunological and neurological gene expression patterns in Alzheimer\u2019s disease tissues. Exp Cell Res 313:450\u2013461","journal-title":"Exp Cell Res"},{"key":"1681_CR31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neulet.2009.09.017","volume":"465","author":"K Ahn","year":"2009","unstructured":"Ahn K, Song JH, Kim DK, Park MH, Jo SA, Koh YH (2009) Ubc9 gene polymorphisms and late-onset Alzheimer\u2019s disease in the Korean population: a genetic association study. Neurosci Lett 465:272\u2013275","journal-title":"Neurosci Lett"},{"key":"1681_CR32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-6-12","volume":"6","author":"CA Akar","year":"2009","unstructured":"Akar CA, Feinstein DL (2009) Modulation of inducible nitric oxide synthase expression by sumoylation. J Neuroinflamm 6:12","journal-title":"J Neuroinflamm"},{"key":"1681_CR33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neulet.2011.07.045","volume":"502","author":"LE McMillan","year":"2011","unstructured":"McMillan LE, Brown JT, Henley JM, Cimarosti H (2011) Profiles of SUMO and ubiquitin conjugation in an Alzheimer\u2019s disease model. Neurosci Lett 502:201\u2013208","journal-title":"Neurosci Lett"},{"key":"1681_CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neulet.2012.04.051","volume":"518","author":"QG Yang","year":"2012","unstructured":"Yang QG, Wang F, Zhang Q, Xu WR, Chen YP, Chen GH (2012) Correlation of increased hippocampal Sumo3 with spatial learning ability in old C57BL\/6 mice. Neurosci Lett 518:75\u201379","journal-title":"Neurosci Lett"},{"key":"1681_CR35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.neurobiolaging.2012.08.005","volume":"34","author":"SM Yun","year":"2013","unstructured":"Yun SM, Cho SJ, Song JC, Song SY, Jo SA, Jo C, Yoon K, Tanzi RE, Choi EJ, Koh YH (2013) SUMO1 modulates A\u03b2 generation via BACE1 accumulation. Neurobiol Aging 34:650\u2013662","journal-title":"Neurobiol Aging"},{"key":"1681_CR36","first-page":"1","volume":"5","author":"R Nistic\u00f2","year":"2014","unstructured":"Nistic\u00f2 R, Ferraina C, Marconi V, Blandini F, Negri L, Egebjerg J, Feligioni M (2014) Age-related changes of protein SUMOylation balance in the A\u03b2PP Tg2576 mouse model of Alzheimer\u2019s disease. Front Pharmacol 5:1\u20139","journal-title":"Front Pharmacol"},{"key":"1681_CR37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0896-6273(92)90117-V","volume":"8","author":"M Goedert","year":"1992","unstructured":"Goedert M, Spillantini MG, Cairns NJ, Crowther RA (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8:159\u2013168","journal-title":"Neuron"},{"key":"1681_CR38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2008.06.012","volume":"441","author":"KM Takahashi","year":"2008","unstructured":"Takahashi KM, Ishida M, Komano H, Takahashi H (2008) SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice. Neurosci Lett 441:90\u201393","journal-title":"Neurosci Lett"},{"key":"1681_CR39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1471-4159.2002.01137.x","volume":"83","author":"DC David","year":"2002","unstructured":"David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG (2002) Proteasomal degradation of tau protein. J Neurochem 83:176\u2013185","journal-title":"J Neurochem"},{"key":"1681_CR40","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1074\/jbc.M305838200","volume":"279","author":"H Shimura","year":"2004","unstructured":"Shimura H, Schwartz D, Gygi SP, Kosik KS (2004) CHIPHsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem 279:4869\u20134876","journal-title":"J Biol Chem"},{"key":"1681_CR41","doi-asserted-by":"crossref","first-page":"16586","DOI":"10.1073\/pnas.1417548111","volume":"111","author":"HB Luo","year":"2014","unstructured":"Luo HB, Xia YY, Shu XJ, Liu ZC, Feng Y, Liu XH et al (2014) SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination. Proc Natl Acad Sci USA 111:16586\u201316591","journal-title":"Proc Natl Acad Sci USA"},{"key":"1681_CR42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbrc.2008.07.109","volume":"374","author":"YQ Zhang","year":"2008","unstructured":"Zhang YQ, Sarge KD (2008) Sumoylation of amyloid precursor protein negatively regulates A\u03b2 aggregate levels. Biochem Biophys Res Commun 374:673\u2013678","journal-title":"Biochem Biophys Res Commun"},{"key":"1681_CR43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0969-9961(03)00104-9","volume":"14","author":"Y Luo","year":"2003","unstructured":"Luo Y, Bolon B, Damore MA, Fitzpatrick D, Liu H, Zhang J, Yan Q, Vassar R, Citron M (2003) BACE1 (\u03b2-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time. Neurobiol Dis 14:81\u201388","journal-title":"Neurobiol Dis"},{"key":"1681_CR44","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.biocel.2009.05.001","volume":"41","author":"A Jourdain","year":"2009","unstructured":"Jourdain A, Martinou JC (2009) Mitochondrial outer-membrane permeabilization and remodelling in apoptosis. Int J Biochem Cell Biol 41:1884\u20131889","journal-title":"Int J Biochem Cell Biol"},{"key":"1681_CR45","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1091\/mbc.E04-04-0294","volume":"15","author":"YJ Lee","year":"2004","unstructured":"Lee YJ, Jeong SY, Karbowski M, Smith CL, Youle RJ (2004) Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 15:5001\u20135011","journal-title":"Mol Biol Cell"},{"key":"1681_CR46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molcel.2004.09.026","volume":"16","author":"G Szabadkai","year":"2004","unstructured":"Szabadkai G, Simoni AM, Chami M, Wieckowski MR, Youle RJ et al (2004) Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosis. Mol Cell 16:59\u201368","journal-title":"Mol Cell"},{"key":"1681_CR47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","volume":"67","author":"PH Reddy","year":"2011","unstructured":"Reddy PH, Reddy TP, Manczak M, Calkins MJ, Shirendeb U et al (2011) Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res Rev 67:103\u2013118","journal-title":"Brain Res Rev"},{"key":"1681_CR48","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cub.2004.02.004","volume":"14","author":"Z Harder","year":"2004","unstructured":"Harder Z, Zunino R, McBride H (2004) Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr Biol 14:340\u2013345","journal-title":"Curr Biol"},{"key":"1681_CR49","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1096\/fj.09-136630","volume":"23","author":"C Figueroa-Romero","year":"2009","unstructured":"Figueroa-Romero C, I\u00f1iguez-Lluh\u00ed JA, Stadler J, Chang CR, Arnoult D, Keller PJ, Hong Y, Blackstone C, Feldman EL (2009) SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J 23:3917\u20133927","journal-title":"FASEB J"},{"key":"1681_CR50","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","volume":"20","author":"M Manczak","year":"2011","unstructured":"Manczak M, Calkins MJ, Reddy PH (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer\u2019s disease: implications for neuronal damage. Hum Mol Genet 20:2495\u20132509","journal-title":"Hum Mol Genet"},{"key":"1681_CR51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrn2417","volume":"9","author":"AB Knott","year":"2008","unstructured":"Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E (2008) Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9:505\u2013518","journal-title":"Nat Rev Neurosci"},{"key":"1681_CR52","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/hmg\/dds072","volume":"21","author":"M Manczak","year":"2012","unstructured":"Manczak M, Reddy PH (2012) Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer\u2019s disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet 21:2538\u20132547","journal-title":"Hum Mol Genet"},{"key":"1681_CR53","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Su B, Lee HG, Li X, Perry G et al (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease. J Neurosci 29:9090\u20139103","journal-title":"J Neurosci"},{"key":"1681_CR54","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/emboj.2013.65","volume":"32","author":"C Guo","year":"2013","unstructured":"Guo C, Hildick KL, Luo J, Dearden L, Wilkinson KA, Henley JM (2013) SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia. EMBO J 32:1514\u20131528","journal-title":"EMBO J"},{"key":"1681_CR55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<24::AID-JNR4>3.0.CO;2-N","volume":"58","author":"DL Alkon","year":"1999","unstructured":"Alkon DL (1999) Ionic conductance determinants of synaptic memory nets and their implications for Alzheimer\u2019s disease. J Neurosci Res 58:24\u201332","journal-title":"J Neurosci Res"},{"key":"1681_CR56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuropharm.2014.12.033","volume":"92","author":"L Wang","year":"2015","unstructured":"Wang L, Kang H, Li Y, Shui Y, Yamamoto R, Sugai T, Kato N (2015) Cognitive recovery by chronic activation of the large-conductance calcium-activated potassium channel in a mouse model of Alzheimer\u2019s disease. Neuropharmacol 92:8\u201315","journal-title":"Neuropharmacol"},{"key":"1681_CR57","doi-asserted-by":"crossref","first-page":"e78036","DOI":"10.1371\/journal.pone.0078036","volume":"8","author":"P Campolongo","year":"2013","unstructured":"Campolongo P, Ratano P, Ciotti MT, Florenzano F, Nori SL, Marolda R, Palmery M, Rinaldi AM, Zona C, Possenti R, Calissano P, Severini C (2013) Systemic administration of substance P recovers beta amyloid-induced cognitive deficits in rat: involvement of Kv potassium channels. PLoS One 8:e78036","journal-title":"PLoS One"},{"key":"1681_CR58","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.neuron.2014.07.042","volume":"83","author":"Y Qi","year":"2014","unstructured":"Qi Y, Wang J, Bomben VC, Li DP, Chen SR, Sun H, Xi Y, Reed JG, Cheng J, Pan HL, Noebels JL, Yeh ET (2014) Hyper-SUMOylation of the Kv7 potassium channel diminishes the M-current leading to seizures and sudden death. Neuron 83:1159\u20131171","journal-title":"Neuron"},{"key":"1681_CR59","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1085\/jgp.201110604","volume":"137","author":"LD Plant","year":"2011","unstructured":"Plant LD, Dowdell EJ, Dementieva IS, Marks JD, Goldstein SA (2011) SUMO modification of cell surface Kv2.1 potassium channels regulates the activity of rat hippocampal neurons. J Gen Physiol 137:441\u2013454","journal-title":"J Gen Physiol"},{"key":"1681_CR60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature05736","volume":"447","author":"S Martin","year":"2007","unstructured":"Martin S, Nishimune A, Mellor JR, Henley JM (2007) SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 447:321\u2013325","journal-title":"Nature"},{"key":"1681_CR61","doi-asserted-by":"crossref","first-page":"19772","DOI":"10.1073\/pnas.1111575108","volume":"108","author":"FA Konopacki","year":"2011","unstructured":"Konopacki FA, Jaafari N, Rocca DL, Wilkinson KA, Chamberlain S et al (2011) Agonist-induced PKC phosphorylation regulates GluK2 SUMOylation and kainate receptor endocytosis. Proc Natl Acad Sci USA 108:19772\u201319777","journal-title":"Proc Natl Acad Sci USA"},{"key":"1681_CR62","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nn.3089","volume":"15","author":"SE Chamberlain","year":"2012","unstructured":"Chamberlain SE, Gonzalez-Gonzalez IM, Wilkinson KA, Konopacki FA, Kantamneni S et al (2012) SUMOylation and phosphorylation of GluK2 regulate kainate receptor trafficking and synaptic plasticity. Nat Neurosci 15:845\u2013852","journal-title":"Nat Neurosci"},{"key":"1681_CR63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4161\/cib.19195","volume":"5","author":"KA Wilkinson","year":"2012","unstructured":"Wilkinson KA, Konopacki F, Henley JM (2012) Modification and movement: phosphorylation and SUMOylation regulate endocytosis of GluK2-containing kainate receptors. Commun Integr Biol. 5:223\u2013226","journal-title":"Commun Integr Biol."},{"key":"1681_CR64","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000067427","volume":"11","author":"HG Lee","year":"2002","unstructured":"Lee HG, Zhu X, Ghanbari HA, Ogawa O, Raina AK, O\u2019Neill MJ, Perry G, Smith MA (2002) Differential regulation of glutamate receptors in Alzheimer\u2019s disease. Neurosignals 11:282\u2013292","journal-title":"Neurosignals"},{"key":"1681_CR65","doi-asserted-by":"crossref","first-page":"22781","DOI":"10.1074\/jbc.M112.356337","volume":"287","author":"TJ Craig","year":"2012","unstructured":"Craig TJ, Jaafari N, Petrovic MM, Rubin PP, Mellor JR et al (2012) Homeostatic synaptic scaling is regulated by protein SUMOylation. J Biol Chem 287:22781\u201322788","journal-title":"J Biol Chem"},{"key":"1681_CR66","doi-asserted-by":"crossref","first-page":"e52345","DOI":"10.1371\/journal.pone.0052345","volume":"8","author":"N Jaafari","year":"2013","unstructured":"Jaafari N, Konopacki FA, Owen TF, Kantamneni S, Rubin P, Craig TJ, Wilkinson KA, Henley JM (2013) SUMOylation is required for glycine-induced increases in AMPA receptor surface expression (ChemLTP) in hippocampal neurons. PLoS One 8:e52345","journal-title":"PLoS One"},{"key":"1681_CR67","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuron.2006.10.035","volume":"52","author":"H Hsieh","year":"2006","unstructured":"Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R (2006) AMPAR removal underlies A\u03b2-induced synaptic depression and dendritic spine loss. Neuron 52:831\u2013843","journal-title":"Neuron"},{"key":"1681_CR68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.neuint.2005.05.005","volume":"47","author":"L Struzynska","year":"2005","unstructured":"Struzynska L, Chalimoniuk M, Sulkowski G (2005) Changes in expression of neuronal and glial glutamate transporters in lead-exposed adult rat brain. Neurochem Int 47:326\u2013333","journal-title":"Neurochem Int"},{"key":"1681_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1\u2013105","journal-title":"Prog Neurobiol"},{"key":"1681_CR70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0197-0186(03)00024-X","volume":"43","author":"C Bonde","year":"2003","unstructured":"Bonde C, Sarup A, Schousboe A, Gegelashvili G, Zimmer J, Noraberg J (2003) Neurotoxic and Neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions. Neurochem Int 43:371\u2013380","journal-title":"Neurochem Int"},{"key":"1681_CR71","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","volume":"31","author":"JE Simpson","year":"2010","unstructured":"Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, Savva G, Brayne C, Wharton SB (2010) M.R.C. Cognitive Function Ageing Neuropathology Study Group, astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging 31:578\u2013590","journal-title":"Neurobiol Aging"},{"key":"1681_CR72","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1471-4159.2010.06661.x","volume":"113","author":"G Tian","year":"2010","unstructured":"Tian G, Kong Q, Lai L, Ray-Chaudhury A, Lin CL (2010) Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer\u2019s disease. J Neurochem 113:978\u2013989","journal-title":"J Neurochem"},{"key":"1681_CR73","doi-asserted-by":"crossref","first-page":"553.e1","DOI":"10.1016\/j.neurobiolaging.2010.03.008","volume":"32","author":"HA Scott","year":"2011","unstructured":"Scott HA, Gebhardt FM, Mitrovic AD, Vandenberg RJ, Dodd PR (2011) Glutamate transporter variants reduce glutamate uptake in Alzheimer\u2019s disease. Neurobiol Aging 32:553.e1\u2013553.e11","journal-title":"Neurobiol Aging"},{"key":"1681_CR74","first-page":"1121.e1","volume":"33","author":"T Cassano","year":"2011","unstructured":"Cassano T, Serviddio G, Gaetani S, Romano A, Dipasquale P, Cianci S, Bellanti F, Laconca L, Romano AD, Padalino I, Laferla FM, Nicoletti F, Cuomo V, Vendemiale G (2011) Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease. Neurobiol Aging. 33:1121.e1\u20131121.e12","journal-title":"Neurobiol Aging."},{"key":"1681_CR75","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2010.08.030","volume":"226","author":"TCB Piermartiri","year":"2010","unstructured":"Piermartiri TCB, Figueiredo CP, Rial D, Duarte FS, Bezerra SC, Mancini G, De Bem AF, Prediger RDS, Tasca CI (2010) Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-\u03b21\u201340 administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. Exp Neurol 226:274\u2013284","journal-title":"Exp Neurol"},{"key":"1681_CR76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/AN20130017","volume":"5","author":"M Kulijewicz-Nawrot","year":"2013","unstructured":"Kulijewicz-Nawrot M, Sykov\u00e1 E, Chv\u00e1tal A, Verkhratsky A, Rodr\u00edguez JJ (2013) Astrocytes and glutamate homoeostasis in Alzheimer\u2019s disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex. ASN Neurol 5:273\u2013282","journal-title":"ASN Neurol"},{"key":"1681_CR77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bjp.0706949","volume":"150","author":"PM Beart","year":"2007","unstructured":"Beart PM, O\u2019Shea RD (2007) Transporters for l-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150:5\u201317","journal-title":"Br J Pharmacol"},{"key":"1681_CR78","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/glia.21218","volume":"59","author":"E Foran","year":"2011","unstructured":"Foran E, Bogush A, Goffredo M, Roncaglia P, Gustincich S, Pasinelli P, Trotti D (2011) Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2. Glia 59:1719\u20131731","journal-title":"Glia"},{"key":"1681_CR79","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/glia.22677","volume":"62","author":"E Foran","year":"2014","unstructured":"Foran E, Rosenblum L, Bogush A, Pasinelli P, Trotti D (2014) Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization. Glia 62:1241\u20131253","journal-title":"Glia"},{"key":"1681_CR80","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","volume":"357","author":"WK Alderton","year":"2001","unstructured":"Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593\u2013615","journal-title":"Biochem J"},{"key":"1681_CR81","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0006-8993(97)00653-7","volume":"768","author":"JL Goodwin","year":"1997","unstructured":"Goodwin JL, Kehrli ME Jr, Uemura E (1997) Integrin Mac-1 and \u03b2-amyloid in microglial release of nitric oxide. Brain Res 768:279\u2013286","journal-title":"Brain Res"},{"key":"1681_CR82","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1073\/pnas.95.10.5795","volume":"95","author":"KT Akama","year":"1998","unstructured":"Akama KT, Albanese C, Pestell RG, Van Eldik LJ (1998) Amyloid \u03b2-peptide stimulates nitric oxide production in astrocytes through an NFk\u03b2-dependent mechanism. Proc Natl Acad Sci USA 95:5795\u20135800","journal-title":"Proc Natl Acad Sci USA"},{"key":"1681_CR83","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1006\/bbrc.1996.1197","volume":"225","author":"F Rossi","year":"1996","unstructured":"Rossi F, Bianchini E (1996) Synergistic induction of nitric oxide by \u03b2-amyloid and cytokines in astrocytes. Biochem Biophys Res Commun 225:474\u2013478","journal-title":"Biochem Biophys Res Commun"},{"key":"1681_CR84","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","volume":"21","author":"CK Combs","year":"2001","unstructured":"Combs CK, Karlo JC, Kao SC, Landreth GE (2001) \u03b2-Amyloid stimulation of microglia and monocytes results in TNF\u03b1-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21:1179\u20131188","journal-title":"J Neurosci"},{"key":"1681_CR85","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tibs.2003.09.002","volume":"28","author":"F Melchior","year":"2003","unstructured":"Melchior F, Schergaut M, Pichler A (2003) SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem Sci 28:612\u2013618","journal-title":"Trends Biochem Sci"},{"key":"1681_CR86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2013.04.050","volume":"546","author":"JB Hoppe","year":"2013","unstructured":"Hoppe JB, Rattray M, Tu H, Salbego CG, Cimarosti H (2013) SUMO-1 conjugation blocks \u03b2-amyloid induced astrocyte reactivity. Neurosci Lett 546:51\u201356","journal-title":"Neurosci Lett"},{"key":"1681_CR87","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1073\/pnas.0337412100","volume":"100","author":"KM Comerford","year":"2003","unstructured":"Comerford KM, Leonard MO, Karhausen J, Carey R, Colgan SP, Taylor CT (2003) Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci USA 100:986\u2013991","journal-title":"Proc Natl Acad Sci USA"},{"key":"1681_CR88","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer\u2019s disease. J Neurochem 104:1433\u20131439","journal-title":"J Neurochem"},{"key":"1681_CR89","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1874091X00802010067","volume":"2","author":"L Eun Jeoung","year":"2008","unstructured":"Eun Jeoung L, Sung Hee H, Jaesun C, Sung Hwa S, Kwang Hum Y, Min Kyoung K et al (2008) Regulation of glycogen synthase kinase 3\u03b2 functions by modification of the small ubiquitin-like modifier. Open Biochem J 2:67\u201376","journal-title":"Open Biochem J"},{"key":"1681_CR90","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI64516","volume":"123","author":"PT Ly","year":"2013","unstructured":"Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A, Zhang M, Yang Y, Cai F, Woodgett J, Song W (2013) Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest 123:224\u2013235","journal-title":"J Clin Invest"},{"key":"1681_CR91","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.nbd.2008.12.014","volume":"33","author":"A Colombo","year":"2009","unstructured":"Colombo A, Bastone A, Ploia C, Sclip A, Salmona M, Forloni G, Borsello T (2009) JNK regulates APP cleavage and degradation in a model of Alzheimer\u2019s disease. Neurobiol Dis 33:518\u2013525","journal-title":"Neurobiol Dis"},{"key":"1681_CR92","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/JAD-2011-110320","volume":"26","author":"C Ploia","year":"2011","unstructured":"Ploia C, Antoniou X, Sclip A, Grande V, Cardinetti D, Colombo A, Canu N, Benussi L, Ghidoni R, Forloni G, Borsello T (2011) JNK plays a key role in tau hyperphosphorylation in Alzheimer\u2019s disease models. J Alzheimer\u2019s Dis 26:315\u2013329","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1681_CR93","doi-asserted-by":"crossref","first-page":"e28185","DOI":"10.1371\/journal.pone.0028185","volume":"6","author":"M Feligioni","year":"2011","unstructured":"Feligioni M, Brambilla E, Camassa A, Sclip A, Arnaboldi A, Morelli F, Antoniou X, Borsello T (2011) Crosstalk between JNK and SUMO signaling pathways: deSUMOylation is protective against H2O2-induced cell injury. PLoS One 6:e28185","journal-title":"PLoS One"},{"key":"1681_CR94","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12017-013-8259-5","volume":"15","author":"K Eckermann","year":"2013","unstructured":"Eckermann K (2013) SUMO and Parkinson\u2019s disease. Neuromol Med 15:737\u2013759","journal-title":"Neuromol Med"},{"key":"1681_CR95","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molcel.2004.11.007","volume":"16","author":"R Boggio","year":"2004","unstructured":"Boggio R, Colombo R, Hay RT, Draetta GF, Chiocca S (2004) A mechanism for inhibiting the SUMO pathway. Mol Cell 16:549\u2013561","journal-title":"Mol Cell"},{"key":"1681_CR96","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/cb400177q","volume":"8","author":"IG Madu","year":"2013","unstructured":"Madu IG, Namanja AT, Su Y, Wong S, Li YJ, Chen Y (2013) Identification and characterization of a new chemotype of noncovalent SENP inhibitors. ACS Chem Biol 8:1435\u20131441","journal-title":"ACS Chem Biol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1681-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-015-1681-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1681-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T18:02:32Z","timestamp":1567015352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-015-1681-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["1681"],"URL":"https:\/\/doi.org\/10.1007\/s11064-015-1681-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,31]]}}}